Tags:AutomationBioTechDataDrugHumanMedtechPlatformResearchScience
Hexagon Bio is a data-driven biopharma company developing targeted small molecule therapeutics. Our proprietary platform combines data science, genomics, synthetic biology, chemistry and automation to discover potent, evolutionarily-refined small molecules and their cognate targets directly from DNA sequences. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs.
Location: United States, California, Menlo Park
Member count: 51-200
Total raised: $232.3M

Investors 4

Funding Rounds 4

DateSeriesAmountInvestorsDeal News
13.02.2023Series B$77.3M-hitconsult...
26.09.2022Series A$47M-greenqueen...
22.09.2021-$61MNextech In...fiercebiot...
15.09.2020Series A$47M-twosigmave...

Mentions in press and media 17

DateTitleDescriptionCategoryAuthorSource
13.02.2023Hexagon Bi...---globenewsw...
13.02.2023Hexagon Bi...What You Should Know:-Fred Penni...hitconsult...
26.09.2022Hexagon Bi...3 Mins Read California-based ...--greenqueen...
07.10.2021Pluton Bio...Many of the problems we face t...agricultur...Devin Cold...techcrunch...
27.09.2021Digital he...UnitedHealthcare makes Apple F...-Kristin Ka...vator.tv/n...
23.09.2021Daily fund...NTWRK raised $50M; Bigeye land...-Kristin Ka...vator.tv/n...
22.09.2021Hexagon Bi...Hexagon Bio, a biopharmaceutic...--marketscre...
22.09.2021Hexa­gon B...A year af­ter rais­ing a $47 m...FinancingPaul Schlo...endpts.com...
22.09.2021Fungi fund...We all want to be the fungi. H...Biotech-fiercebiot...
29.12.2020ИИ-итоги у...Мы в Cleverbots собрали все са...Machine le...Cleverbotsvc.ru/ml/1...
Show more